 |
PDBsum entry 5hu9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
5hu9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Discovery and characterization of a novel potent type ii native and mutant bcr-Abl inhibitor (chmfl-074) for chronic myeloid leukemia (cml).
|
|
|
Authors
|
|
F.Liu,
B.Wang,
Q.Wang,
Z.Qi,
C.Chen,
L.L.Kong,
J.Y.Chen,
X.Liu,
A.Wang,
C.Hu,
W.Wang,
H.Wang,
F.Wu,
Y.Ruan,
S.Qi,
J.Liu,
F.Zou,
Z.Hu,
W.Wang,
L.Wang,
S.Zhang,
C.H.Yun,
Z.Zhai,
J.Liu,
Q.Liu.
|
|
|
Ref.
|
|
Oncotarget, 2016,
7,
45562-45574.
[DOI no: ]
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
